iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

ICAD Stock  USD 2.02  0.04  1.94%   
About 62% of Icad's investor base is looking to short. The analysis of the overall investor sentiment regarding icad inc suggests that many traders are alarmed. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
  
NASHUA, N.H., May 02, 2024 -- iCAD, Inc. , a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at 1000 AM Eastern Time on Wednesday, May 15, 2024. Earnings call details are as follows Domestic 877-545-0523International 973-528-0016Participant Access Code 730845Webcast httpswww.webcaster4.comWebcastPag

Read at finance.yahoo.com
Yahoo News
  

Icad Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Icad can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Icad Fundamental Analysis

We analyze Icad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

Icad is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

icad inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Icad stock to make a market-neutral strategy. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics with similar companies.

Peers

Icad Related Equities

AIMDAinos   54.72   
0%
100.0%
NVRONevro Corp   2.43   
0%
4.0%
NVNOEnVVeno Medical   2.38   
0%
4.0%
ESTAEstablishment Labs   0.84   
0%
1.0%
PROFProfound Medical   0.51   
0%
1.0%
SRDXSurModics   0.48   
0%
1.0%
BMRABiomerica     
0%
1.0%
SSKNSTRATA Skin   0.33   
1.0%
0%
SIBNSi Bone   1.05   
1.0%
0%
CVRXCVRx   1.25   
2.0%
0%
FNAParagon 28   1.56   
2.0%
0%
LNSRLENSAR   1.85   
3.0%
0%
SGHTSight Sciences   2.58   
4.0%
0%
MOVEMovano   2.81   
5.0%
0%
AXGNAxogen   9.62   
17.0%
0%

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance